HK1068949A1 - Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus - Google Patents

Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus

Info

Publication number
HK1068949A1
HK1068949A1 HK05100802A HK05100802A HK1068949A1 HK 1068949 A1 HK1068949 A1 HK 1068949A1 HK 05100802 A HK05100802 A HK 05100802A HK 05100802 A HK05100802 A HK 05100802A HK 1068949 A1 HK1068949 A1 HK 1068949A1
Authority
HK
Hong Kong
Prior art keywords
coagulase
cross
staphylococcus aureus
polyclonal antibodies
surface proteins
Prior art date
Application number
HK05100802A
Other languages
English (en)
Inventor
Foster Timothy
Roche Fiona
Patti Joseph
Hutchins Jeff
Speziale Pietro
Pallen Mark
Original Assignee
Inhibitex Inc
Trinity College Dublin
Univ Pavia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhibitex Inc, Trinity College Dublin, Univ Pavia filed Critical Inhibitex Inc
Publication of HK1068949A1 publication Critical patent/HK1068949A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK05100802A 2001-06-15 2005-01-31 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus HK1068949A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29809801P 2001-06-15 2001-06-15
PCT/US2002/019220 WO2002102829A2 (en) 2001-06-15 2002-06-17 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus

Publications (1)

Publication Number Publication Date
HK1068949A1 true HK1068949A1 (en) 2005-05-06

Family

ID=23149018

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05100802A HK1068949A1 (en) 2001-06-15 2005-01-31 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus

Country Status (9)

Country Link
US (3) US6841154B2 (xx)
EP (3) EP2339344A1 (xx)
JP (2) JP4424984B2 (xx)
CN (1) CN100359327C (xx)
AU (2) AU2002322127B2 (xx)
CA (1) CA2450939C (xx)
HK (1) HK1068949A1 (xx)
MX (1) MXPA03011701A (xx)
WO (1) WO2002102829A2 (xx)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020092987A1 (en) * 1998-09-05 2002-07-18 Taehee Cho Photo detect device using quantum dots and materialization method thereof
AT410798B (de) 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
CA2808598A1 (en) * 2001-08-02 2003-02-13 University Of Sheffield Antigenic polypeptides
EP1545617A1 (en) * 2002-10-03 2005-06-29 Intercell AG Use of molecules which interact with the haptoglobin receptor ligand binding
NZ561879A (en) * 2003-03-07 2009-05-31 Wyeth Corp Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
SI1651166T1 (sl) * 2003-07-24 2010-06-30 Merck Sharp & Dohme Polipeptidi za induciranje zaščitnega imunskegaodgovora proti stafilokoknem eureusu
AU2005214061B2 (en) * 2004-02-18 2010-02-04 Merck Sharp & Dohme Corp. Polypeptides for inducing a protective immune response against Staphylococcus aureus
US20070172498A1 (en) * 2004-02-27 2007-07-26 Anderson Annaliesa S Polypeptides for inducing a protective immune response against staphyloococcus aureus
EP1791560A4 (en) * 2004-09-17 2009-01-14 Merck & Co Inc POLYPEPTIDES FOR INDUCING AN IMMUNE RESPONSE OF PROTECTION DIRECTED AGAINST STAPHYLOCOCCUS AUREUS
EP1804833A2 (en) 2004-09-22 2007-07-11 GlaxoSmithKline Biologicals SA Staphylococcal immunogenic compositions
KR20070085457A (ko) * 2004-10-25 2007-08-27 더 유니버시티 오브 웨스턴 온타리오 스태필로코쿠스 아우레우스의 철에 의해 조절되는 표면결정인자 ＩｓｄＡ, ＩｓｄＢ, 및 ＩｓｄＣ 기재 백신,조성물 및 방법
AU2006214534B2 (en) 2005-02-14 2012-07-19 Epitopix, Llc Polypeptides from Staphylococcus aureus and methods of use
US8475798B2 (en) * 2005-06-16 2013-07-02 Inhibitex, Inc. Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein
EP2368570A3 (en) * 2006-01-18 2012-05-02 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
EP1996231A4 (en) * 2006-02-22 2010-09-15 Texas A & M Univ Sys ANTIBODIES RECOGNIZING A HIGHLY EXPRESS PUTATIVE ANTIGEN OF SARM-C AND METHODS OF USE
WO2009005536A2 (en) * 2006-11-22 2009-01-08 3M Innovative Properties Company Methods of capturing bacterial whole cells and methods of analyzing samples for bacteria
US20100047252A1 (en) * 2006-11-22 2010-02-25 3M Innovative Properties Company Antibody with protein a selectivity
US7488807B2 (en) * 2006-11-22 2009-02-10 3M Innovative Properties Company Antibody with protein A selectivity
EP2666784B1 (en) 2007-08-31 2017-04-05 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
CA2716706C (en) 2008-03-03 2014-02-18 Irm Llc Compounds and compositions as tlr activity modulators
US8758765B2 (en) 2008-07-29 2014-06-24 The University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
JP2012521441A (ja) 2009-03-23 2012-09-13 エピトピックス，リミティド ライアビリティ カンパニー ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法
AU2010271116B2 (en) 2009-04-03 2015-08-13 University Of Chicago Compositions and methods related to Protein A (SpA) variants
US9517263B2 (en) 2009-06-10 2016-12-13 Glaxosmithkline Biologicals Sa Benzonaphthyridine-containing vaccines
SI2445522T1 (sl) 2009-06-22 2017-10-30 Wyeth Llc Imunogeni sestavki antigenov Staphylococcusa aureusa
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
BR112012004806B8 (pt) 2009-09-02 2022-10-04 Novartis Ag composições imunogênicas que incluem moduladores da atividade de tlr, método para aumento da eficácia da referida composição e uso
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
SG10201501980SA (en) 2009-12-15 2015-05-28 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
JP5848748B2 (ja) 2010-03-23 2016-01-27 アイアールエム・リミテッド・ライアビリティ・カンパニーＩｒｍ，Ｌｌｃ 感染症、炎症、呼吸器疾患などの処置に使用するｔｌｒ２アゴニストとしての化合物（システインベースのリポペプチド）および組成物
CN102268444B (zh) * 2010-06-03 2015-05-13 中国人民解放军军事医学科学院生物工程研究所 金黄色葡萄球菌截短SasA蛋白在大肠杆菌中的表达及应用
ES2655701T3 (es) 2010-07-02 2018-02-21 The University Of Chicago Composiciones y métodos relacionados con variantes de la proteína A (SpA)
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
CA2819120C (en) 2010-12-22 2016-07-05 Wyeth Llc Stable immunogenic compositions of staphylococcus aureus antigens
CN102649817A (zh) * 2011-02-24 2012-08-29 复旦大学 一种抑制细菌生物膜形成的单克隆抗体
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
CA2899787A1 (en) 2013-02-01 2014-08-07 Glaxosmithkline Biologicals Sa Intradermal delivery of immunological compositions comprising toll-like receptor agonists
CN104098693B (zh) * 2014-07-15 2017-05-17 中国人民解放军军事医学科学院生物工程研究所 抗金黄色葡萄球菌SasA抗原的单克隆抗体及其应用
WO2016095832A1 (en) * 2014-12-18 2016-06-23 The University Of Hong Kong Immunotherapeutic targets against staphylococcus aureus
US11446371B2 (en) 2015-11-05 2022-09-20 The Texas A&M University System Targeting of ligand binding sites in ClfA
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
MX2020008417A (es) 2018-02-12 2020-11-11 Inimmune Corp Ligandos de receptores de tipo toll.
WO2022096590A1 (en) 2020-11-04 2022-05-12 Eligo Bioscience Phage-derived particles for in situ delivery of dna payload into c. acnes population

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US519596A (en) 1894-05-08 Tian voigt
JPS4954801A (xx) 1972-09-27 1974-05-28
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US5981216A (en) 1985-04-01 1999-11-09 Alusuisse Holdings A.G. Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
US5320951A (en) 1987-06-01 1994-06-14 Hoeoek Magnus Fibronectin binding protein as well as its preparation
US5571514A (en) 1987-06-01 1996-11-05 Alfa Laval Ab Fibronectin binding protein as well as its preparation
SE8801894D0 (sv) 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
US5789549A (en) 1988-05-20 1998-08-04 Alfa Laval Agri International Aktiebolag Fibronectin binding protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5440014A (en) 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
US5851794A (en) * 1990-10-22 1998-12-22 Alfa Laval Ab Collagen binding protein as well as its preparation
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
US5980908A (en) 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
CA2155413A1 (en) * 1993-02-05 1994-08-18 Martin Karl Russel Burnham Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
US6008341A (en) 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
US5707702A (en) 1994-12-14 1998-01-13 Brady, Jr.; Robert F. Epoxy pipelining composition and method of manufacture
US6013482A (en) * 1996-10-15 2000-01-11 Smithkline Beecham Plc Cell surface protein compounds
US6737248B2 (en) * 1996-01-05 2004-05-18 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
JP2001505061A (ja) * 1996-02-29 2001-04-17 ワシントン ユニヴァーシティ バクテリア性エラスチン結合タンパク、これをコードする核酸配列およびこれを使用した診断並びに治療方法
CA2255669A1 (en) 1996-05-16 1997-11-20 The Texas A & M University System Collagen binding protein compositions and methods of use
SE9602496D0 (sv) 1996-06-20 1996-06-20 Bengt Guss Method and means for producing a fibrinogen binding protein and its use in biotechnology
US6294177B1 (en) * 1996-09-11 2001-09-25 Nabi Staphylococcus aureus antigen-containing whole cell vaccine
CA2310217A1 (en) * 1997-11-26 1999-06-03 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
CA2341177A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
WO2000012689A1 (en) * 1998-08-31 2000-03-09 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Polypeptides and polynucleotides from coagulase-negative staphylococci
WO2000071585A1 (en) 1999-05-03 2000-11-30 Medarex, Inc. Human antibodies to staphylococcus aureus
GB0014907D0 (en) * 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus

Also Published As

Publication number Publication date
EP2339344A1 (en) 2011-06-29
JP2010047581A (ja) 2010-03-04
EP1423701A4 (en) 2006-03-29
MXPA03011701A (es) 2004-12-06
CA2450939A1 (en) 2002-12-27
EP1423701A2 (en) 2004-06-02
WO2002102829A2 (en) 2002-12-27
US20090202578A1 (en) 2009-08-13
US6841154B2 (en) 2005-01-11
JP4424984B2 (ja) 2010-03-03
WO2002102829A3 (en) 2004-03-25
AU2008249159A1 (en) 2008-12-11
AU2008249159B2 (en) 2011-04-14
CA2450939C (en) 2012-11-06
EP2320233A1 (en) 2011-05-11
AU2002322127B2 (en) 2008-08-21
CN1543569A (zh) 2004-11-03
JP2004534080A (ja) 2004-11-11
US20050106648A1 (en) 2005-05-19
US7968100B2 (en) 2011-06-28
EP1423701B1 (en) 2012-07-25
CN100359327C (zh) 2008-01-02
US20030185833A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
HK1068949A1 (en) Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
DE60222658D1 (de) Monoklonaler anti-cd-40-antikörper
AU2003264009A8 (en) Humanized rabbit antibodies
EP1653801A4 (en) MODIFIED ANTIBODIES HAVING IMPROVED ANTIGEN BINDING AFFINITY
HUP0204074A3 (en) Humanized antibodies that sequester abetha peptide
IL166244A0 (en) Super humanized antibodies
IL155340A0 (en) HUMANIZED ANTI LYMPHOTOXIN-beta-RECEPTOR ANTIBODIES
IL158643A (en) Anti-hmg monoclonal antibodies and compositions containing the same
EP1651659A4 (en) METHOD FOR HUMANIZATION OF MONOCLONAL RABBIT ANTIBODIES
HUP0300841A3 (en) Agonist anti-trk-c monoclonal antibodies
IL156030A0 (en) Humanized antibodies
AU2001268855A1 (en) Single-domain antigen-binding antibody fragments derived from llama antibodies
AU2002251562A1 (en) Anti-CD40 monoclonal antibody
HK1078589A1 (en) Anti-human tenascin monoclonal antibody
EP1607404A4 (en) MONOCLONAL ANTIBODY AND HYBRIDOM THAT PRODUCES THIS
EP1465926A4 (en) METHODS FOR BLOCKING OR REDUCING STAPHYLOCOCCAL NASAL COLONIZATION BY INTRANASAL APPLICATION OF MONOCLONAL ANTIBODIES
GB0008305D0 (en) Treatment of fungal infections
EP1481011A4 (en) MONOCLONAL AND POLYCLONAL ANTIBODIES THAT DETECT COAGULASENEGATIVE STAPHYLOKOCKE PROTEINS
NO20004251D0 (no) Humaniserte anti-CEA monoklonale antistoffer med høy affinitet
AU2003229799A1 (en) Novel humanized anti-vap-1 monoclonal antibody
FI20011055A (fi) Heveiiniä sitovat monoklonaaliset vasta-aineet
EP1455822A4 (en) LYOPHILIZED MONOCLONAL ANTIBODY COMPOSITIONS
EP1446416A4 (en) TUMOR-SPECIFIC MONOCLONAL ANTIBODIES
GB0121727D0 (en) Monoclonal antibodies
IL165753A0 (en) Humanized monoclonal antibody nPAM4

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130617